Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

NDA submission for sevelamer carbonate for patients on dialysis

Dec. 27, 2006

Ardana announces preliminary results in a phase II study in benign prostatic hyperplasia

Dec. 22, 2006

Orphan Therapeutics plans rolling NDA for Lucassin

Dec. 20, 2006

Enrollment completed in phase IIb study of elocalcitol in BPH

Dec. 20, 2006

Roscovitine shows promise in preclinical models of polycystic kidney disease

Dec. 19, 2006

Sanctura XR NDA accepted for review

Dec. 15, 2006

Schwarz Pharma transfers urology R&D project to 4SC

Dec. 15, 2006

New agents for urinary incontinence emerge from Astellas Pharma R&D

Dec. 13, 2006

MM-101 ameliorates vesical dysfunction in diabetes model

Dec. 11, 2006

SMP-986 improves voiding efficiency in anesthetized dogs

Dec. 7, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...